(Q37824622)

23 August 2017

1 reference

title

Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications (English)

1 reference

23 August 2017

0 references

1

Keishi Yamashita

1 reference

23 August 2017

Shinichi Sakuramoto

2

1 reference

23 August 2017

Masahiko Watanabe

series ordinal

3

1 reference

23 August 2017

publication date

30 December 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

41

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

24-38

1 reference

Global cancer statistics, 2002

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Epidemiology of esophageal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

New aspects of Helicobacter pylori infection involvement in gastric oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Defining the Pathologic Diagnosis of Metaplasia, Atrophy, Dysplasia, and Gastric Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Lessons from hereditary colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Recent results of therapy for scirrhous gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Phase II study of weekly paclitaxel by one-hour infusion for advanced gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Isolation of an amplified DNA sequence in stomach cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Expression cDNA Cloning of the KGF Receptor by Creation of a Transforming Autocrine Loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Oncogenes and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

High frequency of mutations of the PIK3CA gene in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIK3CA amplification in gastric carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Dedifferentiation of adenocarcinomas by activation of phosphatidylinositol 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Activation of ErbB3-PI3-kinase pathway is correlated with malignant phenotypes of adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Cell adhesion and signalling by cadherins and Ig-CAMs in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

A causal role for E-cadherin in the transition from adenoma to carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

E-cadherin germline mutations in familial gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Hereditary diffuse gastric cancer: a manifestation of lost cell polarity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Mechanisms inactivating the gene for E-cadherin in sporadic gastric carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Analysis of metastasis suppressing function of E-cadherin in gastric cancer cells by RNAi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

E-cadherin promoter hypermethylation induced by interleukin-1beta treatment or H. pylori infection in human gastric cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

ErbB2 resembles an autoinhibited invertebrate epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Cancer genes and the pathways they control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

TP53 and gastric carcinoma: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Meta-analysis of the relationship between cagA seropositivity and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Sporadic fundic gland polyps: common gastric polyps arising through activating mutations in the beta-catenin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Increased beta-catenin mRNA levels and mutational alterations of the APC and beta-catenin gene are present in intestinal-type gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Altered growth of human colon cancer cell lines disrupted at activated Ki-ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

A phosphatase associated with metastasis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Expression and prognostic impact of PRL-3 in lymph node metastasis of gastric cancer: its molecular mechanism was investigated using artificial microRNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Elevated PRL-3 expression was more frequently detected in the large primary gastric cancer and exhibits a poor prognostic impact on the patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Phosphatase of regenerating liver-3 as a convergent therapeutic target for lymph node metastasis in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

PRL-3 initiates tumor angiogenesis by recruiting endothelial cells in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Identification of integrin alpha1 as an interacting protein of protein tyrosine phosphatase PRL-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Ezrin is a specific and direct target of protein tyrosine phosphatase PRL-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

PRL-3 promotes epithelial mesenchymal transition by regulating cadherin directly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

CpG island methylator phenotype in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

DNA methylation markers in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

PGP9.5 methylation in diffuse-type gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Quantitative hypermethylation of NMDAR2B in human gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

The N-methyl-D-aspartate receptor type 2A is frequently methylated in human colorectal carcinoma and suppresses cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

A promoter methylation pattern in the N-methyl-D-aspartate receptor 2B gene predicts poor prognosis in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

DCC promoter hypermethylation in esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Methylation of the DFNA5 increases risk of lymph node metastasis in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Genome-wide promoter analysis uncovers portions of the cancer methylome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

The role of PGP9.5 as a tumor suppressor gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Neurofilament heavy polypeptide regulates the Akt-beta-catenin pathway in human esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Potential utility of HOP homeobox gene promoter methylation as a marker of tumor aggressiveness in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

DNA hypomethylation leads to elevated mutation rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

DNA hypomethylation in cancer: epigenetic scars of a neoplastic journey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Alterations and hypermethylation of the p14(ARF) gene in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Frequent hypermethylation of the hMLH1 gene promoter in differentiated-type tumors of the stomach with the gastric foveolar phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Sensitive digital quantification of DNA methylation in clinical samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

DNA methyltransferase expression and DNA methylation of CPG islands and peri-centromeric satellite regions in human colorectal and stomach cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Transcriptional inactivation of the tissue inhibitor of metalloproteinase-3 gene by dna hypermethylation of the 5'-CpG island in human gastric cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Causal relationship between the loss of RUNX3 expression and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

DNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Promoter hypermethylation of MGMT is associated with protein loss in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Methylation of O(6)-methylguanine-DNA methyltransferase gene is associated significantly with K-ras mutation, lymph node invasion, tumor staging, and disease free survival in patients with gastric carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Inactivation of retinoic acid receptor beta by promoter CpG hypermethylation in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

HPP1: a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Association of diminished expression of RASSF1A with promoter methylation in primary gastric cancer from patients of central China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Aberrant methylation and histone deacetylation of cyclooxygenase 2 in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Promoter hypermethylation of the Chfr gene in neoplastic and non-neoplastic gastric epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Aberrant methylation of Reprimo in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Reprimo as a potential biomarker for early detection in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Biallelic inactivation of the RIZ1 gene in human gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Aberrant methylation of integrin alpha4 gene in human gastric cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Drastic down-regulation of Krüppel-like factor 4 expression is critical in human gastric cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Aberrant promoter methylation of insulin-like growth factor binding protein-3 gene in human cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Comparison of methylation-specific polymerase chain reaction (MSP) with reverse transcriptase-polymerase chain reaction (RT-PCR) in peripheral blood of gastric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

p16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Promoter hypermethylation correlates with the Hsulf-1 silencing in human breast and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Hop is an unusual homeobox gene that modulates cardiac development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Modulation of cardiac growth and development by HOP, an unusual homeodomain protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Enhancer of polycomb1, a novel homeodomain only protein-binding partner, induces skeletal muscle differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

NECC1, a candidate choriocarcinoma suppressor gene that encodes a homeodomain consensus motif☆☆Sequence data from this article have been deposited with the DDBJ/EMBL/GenBank Data Libraries under Accession No. AB059410

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Homeobox gene HOP has a potential tumor suppressive activity in human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Characterizing the cancer genome in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Promoter methylation and response to chemotherapy and radiation in esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Multigene Methylation Analysis of Gastrointestinal Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Gene silencing of TSPYL5 mediated by aberrant promoter methylation in gastric cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Epigenetic inactivation of protein kinase D1 in gastric cancer and its role in gastric cancer cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Epigenetic down-regulation and suppressive role of DCBLD2 in gastric cancer cell proliferation and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

MAL promoter hypermethylation as a novel prognostic marker in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

ZIC1 is downregulated through promoter hypermethylation in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

CHD5 is down-regulated through promoter hypermethylation in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Silencing of claudin-11 is associated with increased invasiveness of gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

DAP kinase links the control of apoptosis to metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-010-4370-5

E-cadherin gene mutations provide clues to diffuse type gastric carcinomas

21 January 2018

1 reference

12 December 2020

Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer

1 reference

12 December 2020

Promoter methylation of cancer-related genes in gastric carcinoma.

1 reference

12 December 2020

Nodal dissection for patients with gastric cancer: a randomised controlled trial

1 reference

12 December 2020

Aberrant methylation within RUNX3 CpG island associated with the nuclear and mitochondrial microsatellite instability in sporadic gastric cancers. Results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study

1 reference

12 December 2020

Correlation between serum DNA methylation and prognosis in gastric cancer patients

1 reference

12 December 2020

Transcriptional silencing of Cyclooxygenase-2 by hyper-methylation of the 5' CpG island in human gastric carcinoma cells.

1 reference

12 December 2020

DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis

1 reference

12 December 2020

High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study

1 reference

12 December 2020

Possible role of Helicobacter pylori infection in early gastric cancer development

1 reference

12 December 2020

Preferential loss of Death Associated Protein kinase expression in invasive pituitary tumours is associated with either CpG island methylation or homozygous deletion

1 reference

12 December 2020

Glutamate receptor, ionotropic, kainate 2 silencing by DNA hypermethylation possesses tumor suppressor function in gastric cancer.

1 reference

12 December 2020

The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer

1 reference

12 December 2020

Synergistic antitumor effects of FGFR2 inhibitor with 5-fluorouracil on scirrhous gastric carcinoma.

1 reference

12 December 2020

Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type

1 reference

12 December 2020

Clinical application of methylation specific-polymerase chain reaction in serum of patients with gastric cancer

1 reference

12 December 2020

Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability

1 reference

12 December 2020

Distinct methylation pattern and microsatellite instability in sporadic gastric cancer

1 reference

12 December 2020

The association of death-associated protein kinase hypermethylation with early recurrence in superficial bladder cancers.

1 reference

12 December 2020

The erbB3 gene product is a receptor for heregulin

1 reference

12 December 2020

Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers

1 reference

12 December 2020

PRL-3 expression in metastatic cancers

1 reference

12 December 2020

Association of tyrosine PRL-3 phosphatase protein expression with peritoneal metastasis of gastric carcinoma and prognosis

1 reference

12 December 2020

Alterations of p16INK4A and p15INK4B genes in gastric carcinomas

1 reference

12 December 2020

p53 alteration in gastric precancerous lesions.

1 reference

12 December 2020

Comparative study on overexpression of HER2/neu and HER3 in gastric cancer

1 reference

12 December 2020

Diffuse type advanced gastric cancer showing dismal prognosis is characterized by deeper invasion and emerging peritoneal cancer cell: the latest comparative study to intestinal advanced gastric cancer

1 reference

12 December 2020

Concurrent hypermethylation of multiple tumor-related genes in gastric carcinoma and adjacent normal tissues.

1 reference

12 December 2020

Quantitative analysis of tumor-derived methylated RUNX3 sequences in the serum of gastric cancer patients.

1 reference

12 December 2020

Hypermethylation of HPP1 is associated with hMLH1 hypermethylation in gastric adenocarcinomas

1 reference

12 December 2020

NECC1, a candidate choriocarcinoma suppressor gene that encodes a homeodomain consensus motif

1 reference

12 December 2020

Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3

1 reference

12 December 2020

D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer

1 reference

12 December 2020

DNA methylation profile in diffuse type gastric cancer: evidence for hypermethylation of the BRCA1 promoter region in early-onset gastric carcinogenesis.

1 reference

12 December 2020

Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.

1 reference

12 December 2020

Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma.

1 reference

12 December 2020

D2 plus para-aortic lymphadenectomy versus standardized D2 lymphadenectomy in gastric cancer surgery

1 reference

12 December 2020

PRL-3 and PRL-1 promote cell migration, invasion, and metastasis

1 reference

12 December 2020

hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability

1 reference

12 December 2020

Immunohistochemical detection of K-sam protein in stomach cancer

1 reference

12 December 2020

Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.

1 reference

12 December 2020

Effect of promoter methylation of multidrug resistance 1 (MDR1) gene in gastric carcinogenesis

1 reference

12 December 2020

Phosphatase of regenerating liver-3 as a prognostic biomarker in histologically node-negative gastric cancer.

1 reference

12 December 2020

Suppression of tumor growth in human gastric cancer with HER2 overexpression by an anti-HER2 antibody in a murine model.

1 reference

12 December 2020

Comparison of HER2 gene amplification assessed by fluorescence in situ hybridization and HER2 protein expression assessed by immunohistochemistry in gastric cancer.

1 reference

12 December 2020

Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis.

1 reference

12 December 2020

Detection of aberrant methylation as a tumor marker in serum of patients with gastric cancer

1 reference

12 December 2020

Surgical outcome of curative resection in patients with Borrmann type IV gastric carcinoma with particular reference to the extent of lymph node metastasis.

1 reference

12 December 2020

TGF-beta induces apoptosis through Smad-mediated expression of DAP-kinase

1 reference

12 December 2020

PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin beta1-ERK1/2 and-MMP2 signaling

1 reference

12 December 2020

E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas

1 reference

12 December 2020

Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models

1 reference

12 December 2020

Multigene methylation analysis of gastrointestinal tumors: TPEF emerges as a frequent tumor-specific aberrantly methylated marker that can be detected in peripheral blood

1 reference

12 December 2020

Epigenetic silencing of RELN in gastric cancer.

1 reference

12 December 2020

Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium

1 reference

12 December 2020

CpG island methylation in premalignant stages of gastric carcinoma

1 reference

12 December 2020

Comparison of serum aberrant methylation and conventional tumor markers in gastric cancer patients

1 reference

12 December 2020

Epigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer

1 reference

12 December 2020

Helicobacter pylori infection is an independent risk factor for Runx3 methylation in gastric cancer

1 reference

12 December 2020

10.1007/S00595-010-4370-5

Identifiers

DOI

1 reference

23 August 2017

1 reference